Find and Join

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

• Education (and CE) from USP

  For the fourth year in a row, USP will be holding a hybrid live/virtual workshop dedicated to improving the quality of compounding. read more →

• Compounding post-Chevron

  At least three issues affecting pharmacy compounding might be affected by the overturning of the decades-old “Chevron doctrine.” read more →

• 503B sourcing: our state-by-state analysis

  Do you work for one of APC’s PFMs? If you’re with a Pharmacy/Facility Member, you’ve got access to a new resource. read more →

• What we’ll be talking about at CCH

  When we get together on Capitol Hill to meet with legislators and their staffs, as much as we’d like to talk about a half-dozen issues (easily!), we’re going to be focusing on the three most important.  read more →

More News

Earlier this year, APC announced a collaboration with OutcomeMD, a platform that allows compounding pharmacies to measure patient-reported outcomes (PROs) using the same validated measures that FDA requires in new drug approvals. We think that program is key to demonstrating to FDA that the compounded preparations you dispense are actually doing for patients what they are supposed to do.

During a recent APC briefing, Proving Your Value Via Patient-Reported Outcomes, we discussed how important it is to use platforms like OutcomeMD in order to consistently demonstrate the value of your patients’ therapies.

One challenge is the integration of OutcomeMD with your compounding software and your pharmacy workflows. To work through some of those possible issues, we need to know which compounding softwares our members are using the most.

Will you please tell us which compounding software you’re using? This short survey will only take a few minutes.